 | • レポートコード：QYR2104Z1238 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、脳葉酸欠乏症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ロイコボリンカルシウム、葉酸、フォリン酸）、用途別市場規模（病院、薬局、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・脳葉酸欠乏症の市場動向 ・企業の競争状況、市場シェア ・脳葉酸欠乏症の種類別市場規模（ロイコボリンカルシウム、葉酸、フォリン酸） ・脳葉酸欠乏症の用途別市場規模（病院、薬局、クリニック、その他） ・脳葉酸欠乏症の北米市場規模2016-2027（アメリカ、カナダ） ・脳葉酸欠乏症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・脳葉酸欠乏症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脳葉酸欠乏症の中南米市場規模2016-2027（メキシコ、ブラジル） ・脳葉酸欠乏症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Hikma Pharmaceuticals、Eli Lilly and Company、Sagent Pharmaceuticals、Jiangsu Hengrui Medicine、Siemens Healthineers、GE Healthcare、Canon Medical Systems、Fonar Corporation） ・結論 |
Market Analysis and Insights: Global Cerebral Folate Deficiency Market
The global Cerebral Folate Deficiency market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cerebral Folate Deficiency market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cerebral Folate Deficiency market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cerebral Folate Deficiency market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cerebral Folate Deficiency market.
Global Cerebral Folate Deficiency Scope and Market Size
Cerebral Folate Deficiency market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cerebral Folate Deficiency market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Leucovorin Calcium
Folic Acid
Folinic Acid
Segment by Application
Hospital
Pharmacy
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Hikma Pharmaceuticals
Eli Lilly and Company
Sagent Pharmaceuticals
Jiangsu Hengrui Medicine
Siemens Healthineers
GE Healthcare
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cerebral Folate Deficiency Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Leucovorin Calcium
1.2.3 Folic Acid
1.2.4 Folinic Acid
1.3 Market by Application
1.3.1 Global Cerebral Folate Deficiency Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cerebral Folate Deficiency Market Perspective (2016-2027)
2.2 Cerebral Folate Deficiency Growth Trends by Regions
2.2.1 Cerebral Folate Deficiency Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cerebral Folate Deficiency Historic Market Share by Regions (2016-2021)
2.2.3 Cerebral Folate Deficiency Forecasted Market Size by Regions (2022-2027)
2.3 Cerebral Folate Deficiency Industry Dynamic
2.3.1 Cerebral Folate Deficiency Market Trends
2.3.2 Cerebral Folate Deficiency Market Drivers
2.3.3 Cerebral Folate Deficiency Market Challenges
2.3.4 Cerebral Folate Deficiency Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cerebral Folate Deficiency Players by Revenue
3.1.1 Global Top Cerebral Folate Deficiency Players by Revenue (2016-2021)
3.1.2 Global Cerebral Folate Deficiency Revenue Market Share by Players (2016-2021)
3.2 Global Cerebral Folate Deficiency Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cerebral Folate Deficiency Revenue
3.4 Global Cerebral Folate Deficiency Market Concentration Ratio
3.4.1 Global Cerebral Folate Deficiency Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cerebral Folate Deficiency Revenue in 2020
3.5 Cerebral Folate Deficiency Key Players Head office and Area Served
3.6 Key Players Cerebral Folate Deficiency Product Solution and Service
3.7 Date of Enter into Cerebral Folate Deficiency Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cerebral Folate Deficiency Breakdown Data by Type
4.1 Global Cerebral Folate Deficiency Historic Market Size by Type (2016-2021)
4.2 Global Cerebral Folate Deficiency Forecasted Market Size by Type (2022-2027)
5 Cerebral Folate Deficiency Breakdown Data by Application
5.1 Global Cerebral Folate Deficiency Historic Market Size by Application (2016-2021)
5.2 Global Cerebral Folate Deficiency Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cerebral Folate Deficiency Market Size (2016-2027)
6.2 North America Cerebral Folate Deficiency Market Size by Type
6.2.1 North America Cerebral Folate Deficiency Market Size by Type (2016-2021)
6.2.2 North America Cerebral Folate Deficiency Market Size by Type (2022-2027)
6.2.3 North America Cerebral Folate Deficiency Market Size by Type (2016-2027)
6.3 North America Cerebral Folate Deficiency Market Size by Application
6.3.1 North America Cerebral Folate Deficiency Market Size by Application (2016-2021)
6.3.2 North America Cerebral Folate Deficiency Market Size by Application (2022-2027)
6.3.3 North America Cerebral Folate Deficiency Market Size by Application (2016-2027)
6.4 North America Cerebral Folate Deficiency Market Size by Country
6.4.1 North America Cerebral Folate Deficiency Market Size by Country (2016-2021)
6.4.2 North America Cerebral Folate Deficiency Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cerebral Folate Deficiency Market Size (2016-2027)
7.2 Europe Cerebral Folate Deficiency Market Size by Type
7.2.1 Europe Cerebral Folate Deficiency Market Size by Type (2016-2021)
7.2.2 Europe Cerebral Folate Deficiency Market Size by Type (2022-2027)
7.2.3 Europe Cerebral Folate Deficiency Market Size by Type (2016-2027)
7.3 Europe Cerebral Folate Deficiency Market Size by Application
7.3.1 Europe Cerebral Folate Deficiency Market Size by Application (2016-2021)
7.3.2 Europe Cerebral Folate Deficiency Market Size by Application (2022-2027)
7.3.3 Europe Cerebral Folate Deficiency Market Size by Application (2016-2027)
7.4 Europe Cerebral Folate Deficiency Market Size by Country
7.4.1 Europe Cerebral Folate Deficiency Market Size by Country (2016-2021)
7.4.2 Europe Cerebral Folate Deficiency Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cerebral Folate Deficiency Market Size (2016-2027)
8.2 Asia-Pacific Cerebral Folate Deficiency Market Size by Type
8.2.1 Asia-Pacific Cerebral Folate Deficiency Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cerebral Folate Deficiency Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cerebral Folate Deficiency Market Size by Type (2016-2027)
8.3 Asia-Pacific Cerebral Folate Deficiency Market Size by Application
8.3.1 Asia-Pacific Cerebral Folate Deficiency Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cerebral Folate Deficiency Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cerebral Folate Deficiency Market Size by Application (2016-2027)
8.4 Asia-Pacific Cerebral Folate Deficiency Market Size by Region
8.4.1 Asia-Pacific Cerebral Folate Deficiency Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cerebral Folate Deficiency Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cerebral Folate Deficiency Market Size (2016-2027)
9.2 Latin America Cerebral Folate Deficiency Market Size by Type
9.2.1 Latin America Cerebral Folate Deficiency Market Size by Type (2016-2021)
9.2.2 Latin America Cerebral Folate Deficiency Market Size by Type (2022-2027)
9.2.3 Latin America Cerebral Folate Deficiency Market Size by Type (2016-2027)
9.3 Latin America Cerebral Folate Deficiency Market Size by Application
9.3.1 Latin America Cerebral Folate Deficiency Market Size by Application (2016-2021)
9.3.2 Latin America Cerebral Folate Deficiency Market Size by Application (2022-2027)
9.3.3 Latin America Cerebral Folate Deficiency Market Size by Application (2016-2027)
9.4 Latin America Cerebral Folate Deficiency Market Size by Country
9.4.1 Latin America Cerebral Folate Deficiency Market Size by Country (2016-2021)
9.4.2 Latin America Cerebral Folate Deficiency Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cerebral Folate Deficiency Market Size (2016-2027)
10.2 Middle East & Africa Cerebral Folate Deficiency Market Size by Type
10.2.1 Middle East & Africa Cerebral Folate Deficiency Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cerebral Folate Deficiency Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cerebral Folate Deficiency Market Size by Type (2016-2027)
10.3 Middle East & Africa Cerebral Folate Deficiency Market Size by Application
10.3.1 Middle East & Africa Cerebral Folate Deficiency Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cerebral Folate Deficiency Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cerebral Folate Deficiency Market Size by Application (2016-2027)
10.4 Middle East & Africa Cerebral Folate Deficiency Market Size by Country
10.4.1 Middle East & Africa Cerebral Folate Deficiency Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cerebral Folate Deficiency Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Cerebral Folate Deficiency Introduction
11.1.4 Pfizer Revenue in Cerebral Folate Deficiency Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Hikma Pharmaceuticals
11.2.1 Hikma Pharmaceuticals Company Details
11.2.2 Hikma Pharmaceuticals Business Overview
11.2.3 Hikma Pharmaceuticals Cerebral Folate Deficiency Introduction
11.2.4 Hikma Pharmaceuticals Revenue in Cerebral Folate Deficiency Business (2016-2021)
11.2.5 Hikma Pharmaceuticals Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Cerebral Folate Deficiency Introduction
11.3.4 Eli Lilly and Company Revenue in Cerebral Folate Deficiency Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 Sagent Pharmaceuticals
11.4.1 Sagent Pharmaceuticals Company Details
11.4.2 Sagent Pharmaceuticals Business Overview
11.4.3 Sagent Pharmaceuticals Cerebral Folate Deficiency Introduction
11.4.4 Sagent Pharmaceuticals Revenue in Cerebral Folate Deficiency Business (2016-2021)
11.4.5 Sagent Pharmaceuticals Recent Development
11.5 Jiangsu Hengrui Medicine
11.5.1 Jiangsu Hengrui Medicine Company Details
11.5.2 Jiangsu Hengrui Medicine Business Overview
11.5.3 Jiangsu Hengrui Medicine Cerebral Folate Deficiency Introduction
11.5.4 Jiangsu Hengrui Medicine Revenue in Cerebral Folate Deficiency Business (2016-2021)
11.5.5 Jiangsu Hengrui Medicine Recent Development
11.6 Siemens Healthineers
11.6.1 Siemens Healthineers Company Details
11.6.2 Siemens Healthineers Business Overview
11.6.3 Siemens Healthineers Cerebral Folate Deficiency Introduction
11.6.4 Siemens Healthineers Revenue in Cerebral Folate Deficiency Business (2016-2021)
11.6.5 Siemens Healthineers Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Cerebral Folate Deficiency Introduction
11.7.4 GE Healthcare Revenue in Cerebral Folate Deficiency Business (2016-2021)
11.7.5 GE Healthcare Recent Development
11.8 Canon Medical Systems
11.8.1 Canon Medical Systems Company Details
11.8.2 Canon Medical Systems Business Overview
11.8.3 Canon Medical Systems Cerebral Folate Deficiency Introduction
11.8.4 Canon Medical Systems Revenue in Cerebral Folate Deficiency Business (2016-2021)
11.8.5 Canon Medical Systems Recent Development
11.9 Fonar Corporation
11.9.1 Fonar Corporation Company Details
11.9.2 Fonar Corporation Business Overview
11.9.3 Fonar Corporation Cerebral Folate Deficiency Introduction
11.9.4 Fonar Corporation Revenue in Cerebral Folate Deficiency Business (2016-2021)
11.9.5 Fonar Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cerebral Folate Deficiency Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Leucovorin Calcium
Table 3. Key Players of Folic Acid
Table 4. Key Players of Folinic Acid
Table 5. Global Cerebral Folate Deficiency Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cerebral Folate Deficiency Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cerebral Folate Deficiency Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cerebral Folate Deficiency Market Share by Regions (2016-2021)
Table 9. Global Cerebral Folate Deficiency Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cerebral Folate Deficiency Market Share by Regions (2022-2027)
Table 11. Cerebral Folate Deficiency Market Trends
Table 12. Cerebral Folate Deficiency Market Drivers
Table 13. Cerebral Folate Deficiency Market Challenges
Table 14. Cerebral Folate Deficiency Market Restraints
Table 15. Global Cerebral Folate Deficiency Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cerebral Folate Deficiency Market Share by Players (2016-2021)
Table 17. Global Top Cerebral Folate Deficiency Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebral Folate Deficiency as of 2020)
Table 18. Ranking of Global Top Cerebral Folate Deficiency Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cerebral Folate Deficiency Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cerebral Folate Deficiency Product Solution and Service
Table 22. Date of Enter into Cerebral Folate Deficiency Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cerebral Folate Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cerebral Folate Deficiency Revenue Market Share by Type (2016-2021)
Table 26. Global Cerebral Folate Deficiency Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cerebral Folate Deficiency Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cerebral Folate Deficiency Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cerebral Folate Deficiency Revenue Market Share by Application (2016-2021)
Table 30. Global Cerebral Folate Deficiency Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cerebral Folate Deficiency Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cerebral Folate Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cerebral Folate Deficiency Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cerebral Folate Deficiency Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cerebral Folate Deficiency Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cerebral Folate Deficiency Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cerebral Folate Deficiency Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cerebral Folate Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cerebral Folate Deficiency Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cerebral Folate Deficiency Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cerebral Folate Deficiency Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cerebral Folate Deficiency Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cerebral Folate Deficiency Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cerebral Folate Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cerebral Folate Deficiency Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cerebral Folate Deficiency Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cerebral Folate Deficiency Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cerebral Folate Deficiency Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cerebral Folate Deficiency Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cerebral Folate Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cerebral Folate Deficiency Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cerebral Folate Deficiency Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cerebral Folate Deficiency Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cerebral Folate Deficiency Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cerebral Folate Deficiency Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cerebral Folate Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cerebral Folate Deficiency Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cerebral Folate Deficiency Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cerebral Folate Deficiency Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cerebral Folate Deficiency Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cerebral Folate Deficiency Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Cerebral Folate Deficiency Product
Table 65. Pfizer Revenue in Cerebral Folate Deficiency Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Hikma Pharmaceuticals Company Details
Table 68. Hikma Pharmaceuticals Business Overview
Table 69. Hikma Pharmaceuticals Cerebral Folate Deficiency Product
Table 70. Hikma Pharmaceuticals Revenue in Cerebral Folate Deficiency Business (2016-2021) & (US$ Million)
Table 71. Hikma Pharmaceuticals Recent Development
Table 72. Eli Lilly and Company Company Details
Table 73. Eli Lilly and Company Business Overview
Table 74. Eli Lilly and Company Cerebral Folate Deficiency Product
Table 75. Eli Lilly and Company Revenue in Cerebral Folate Deficiency Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly and Company Recent Development
Table 77. Sagent Pharmaceuticals Company Details
Table 78. Sagent Pharmaceuticals Business Overview
Table 79. Sagent Pharmaceuticals Cerebral Folate Deficiency Product
Table 80. Sagent Pharmaceuticals Revenue in Cerebral Folate Deficiency Business (2016-2021) & (US$ Million)
Table 81. Sagent Pharmaceuticals Recent Development
Table 82. Jiangsu Hengrui Medicine Company Details
Table 83. Jiangsu Hengrui Medicine Business Overview
Table 84. Jiangsu Hengrui Medicine Cerebral Folate Deficiency Product
Table 85. Jiangsu Hengrui Medicine Revenue in Cerebral Folate Deficiency Business (2016-2021) & (US$ Million)
Table 86. Jiangsu Hengrui Medicine Recent Development
Table 87. Siemens Healthineers Company Details
Table 88. Siemens Healthineers Business Overview
Table 89. Siemens Healthineers Cerebral Folate Deficiency Product
Table 90. Siemens Healthineers Revenue in Cerebral Folate Deficiency Business (2016-2021) & (US$ Million)
Table 91. Siemens Healthineers Recent Development
Table 92. GE Healthcare Company Details
Table 93. GE Healthcare Business Overview
Table 94. GE Healthcare Cerebral Folate Deficiency Product
Table 95. GE Healthcare Revenue in Cerebral Folate Deficiency Business (2016-2021) & (US$ Million)
Table 96. GE Healthcare Recent Development
Table 97. Canon Medical Systems Company Details
Table 98. Canon Medical Systems Business Overview
Table 99. Canon Medical Systems Revenue in Cerebral Folate Deficiency Business (2016-2021) & (US$ Million)
Table 100. Canon Medical Systems Recent Development
Table 101. Fonar Corporation Company Details
Table 102. Fonar Corporation Business Overview
Table 103. Fonar Corporation Cerebral Folate Deficiency Product
Table 104. Fonar Corporation Revenue in Cerebral Folate Deficiency Business (2016-2021) & (US$ Million)
Table 105. Fonar Corporation Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cerebral Folate Deficiency Market Share by Type: 2020 VS 2027
Figure 2. Leucovorin Calcium Features
Figure 3. Folic Acid Features
Figure 4. Folinic Acid Features
Figure 5. Global Cerebral Folate Deficiency Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Pharmacy Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Cerebral Folate Deficiency Report Years Considered
Figure 11. Global Cerebral Folate Deficiency Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cerebral Folate Deficiency Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cerebral Folate Deficiency Market Share by Regions: 2020 VS 2027
Figure 14. Global Cerebral Folate Deficiency Market Share by Regions (2022-2027)
Figure 15. Global Cerebral Folate Deficiency Market Share by Players in 2020
Figure 16. Global Top Cerebral Folate Deficiency Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebral Folate Deficiency as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cerebral Folate Deficiency Revenue in 2020
Figure 18. Global Cerebral Folate Deficiency Revenue Market Share by Type (2016-2021)
Figure 19. Global Cerebral Folate Deficiency Revenue Market Share by Type (2022-2027)
Figure 20. North America Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cerebral Folate Deficiency Market Share by Type (2016-2027)
Figure 22. North America Cerebral Folate Deficiency Market Share by Application (2016-2027)
Figure 23. North America Cerebral Folate Deficiency Market Share by Country (2016-2027)
Figure 24. United States Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cerebral Folate Deficiency Market Share by Type (2016-2027)
Figure 28. Europe Cerebral Folate Deficiency Market Share by Application (2016-2027)
Figure 29. Europe Cerebral Folate Deficiency Market Share by Country (2016-2027)
Figure 30. Germany Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cerebral Folate Deficiency Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cerebral Folate Deficiency Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cerebral Folate Deficiency Market Share by Region (2016-2027)
Figure 40. China Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cerebral Folate Deficiency Market Share by Type (2016-2027)
Figure 48. Latin America Cerebral Folate Deficiency Market Share by Application (2016-2027)
Figure 49. Latin America Cerebral Folate Deficiency Market Share by Country (2016-2027)
Figure 50. Mexico Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cerebral Folate Deficiency Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cerebral Folate Deficiency Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cerebral Folate Deficiency Market Share by Country (2016-2027)
Figure 56. Turkey Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cerebral Folate Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Cerebral Folate Deficiency Business (2016-2021)
Figure 60. Hikma Pharmaceuticals Revenue Growth Rate in Cerebral Folate Deficiency Business (2016-2021)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Cerebral Folate Deficiency Business (2016-2021)
Figure 62. Sagent Pharmaceuticals Revenue Growth Rate in Cerebral Folate Deficiency Business (2016-2021)
Figure 63. Jiangsu Hengrui Medicine Revenue Growth Rate in Cerebral Folate Deficiency Business (2016-2021)
Figure 64. Siemens Healthineers Revenue Growth Rate in Cerebral Folate Deficiency Business (2016-2021)
Figure 65. GE Healthcare Revenue Growth Rate in Cerebral Folate Deficiency Business (2016-2021)
Figure 66. Canon Medical Systems Revenue Growth Rate in Cerebral Folate Deficiency Business (2016-2021)
Figure 67. Fonar Corporation Revenue Growth Rate in Cerebral Folate Deficiency Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の葉酸＆葉酸塩市場 2021：企業別、地域別、種類・用途別 The Folic Acid and Folate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 世界のアデノシンデアミナーゼ欠損症（ADA）市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Market The global Adenosine Deaminase Deficiency market size is …
- 世界のアデノシンデアミナーゼ欠損症（ADA）治療薬市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Therapeutic Market The global Adenosine Deaminase Deficiency The…
- 世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Treatment Market The global Adenosine Deaminase Deficiency Treat…
- 世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…